Manufacturer record
IBN Herbals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
8 batches manufactured by IBN Herbals (Himachal Pradesh) were declared Not of Standard Quality between February 2020 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
8 records linked to IBN Herbals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Nimesulide & Paracetamol Tablets. | IPL24832Mfg 2024-10 · Exp 2027-09 | Disintegration test : does not comply with IP.Disintegration | SDTL, UttarakhandState lab | May 2026 |
| Vomiban-MD | IMP 24024Mfg 2026-06 · Exp 2026-05 | AssayAssay | Drug Testing Laboratory Baddi, Himanchal PradeshState lab | Jul 2025 |
| Bioglip 1 Tablets | BEL23021Mfg 2023-09 · Exp 2025-08 | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab | Jul 2024 |
| Pantoprazole Sodium Tablets I.P. 40 mg | SL20098Mfg 2020-11 · Exp 2022-10 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2022 |
| Diclofenac Sodium Prolonged Release Tablets IP (FENCO-100 SR) | IDM20020Mfg 2020-05 · Exp 2023-04 | DissolutionDissolution | RDTL GuwahatiState lab | Nov 2021 |
| Diclofenac Sodium Prolonged Release Tablets I.P. | IDM20020Mfg 2020-05 · Exp 2023-04 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Sep 2021 |
| Amlodipine Besilate Tablets IP 5 mg (AMLORACE-5) | GLL19018Mfg 2019-03 · Exp 2022-02 | AssayAssay | RDTL GuwahatiState lab | Jul 2021 |
| Albendazole Tablets I.P. 400mg. (Zenebend) | GLL18001Mfg 2018-01 · Exp 2020-12 | DissolutionDissolution | RDTL GuwahatiState lab | Feb 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.